Suven Life Sciences Ltd Q1 FY24 consolidated loss at Rs. 24.09 crores

Suven Life Sciences Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 9.4369 crores during the period ended June 30, 2023 as compared to Rs. 8.2133 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. -24.0905 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -27.6449 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. -1.10 for the period ended June 30, 2023 as compared to Rs. -1.17 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 9.4369 crs	₹8.2133 crs	14.90%
Net Profit	₹-24.0905 crs	₹-27.6449 crs	12.86%
EPS	₹-1.10	₹-1.17	5.98%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 9.4369 crores during the period ended June 30, 2023 as compared to Rs.3.9750 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.-24.0905 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.-16.3262 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.-1.10 for the period ended June 30, 2023 as compared to Rs.-1.12 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 9.4369 crs	₹3.9750 crs	137.41%
Net Profit	₹-24.0905 crs	₹-16.3262 crs	47.56%
EPS	₹-1.10	₹-1.12	1.79%

Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 66.44 as compared to the previous close of Rs. 62.94. The total number of shares traded during the day was 255569 in over 2324 trades.

The stock hit an intraday high of Rs. 68.30 and intraday low of 63.15. The net turnover during the day was Rs. 16955253.00.

Source : Equity Bulls

Keywords

SuvenLifeSciences Q1FY24 ResultUpdate